Penile Cancer Guidelines
Penile cancer accounts for 0.4% to 0.6% of all malignant neoplasms in the United States and Europe.
In 2010, an estimated 1250 new cases of penile cancer were diagnosed in the United States and there were about 310 related deaths.
For carcinoma in situ and superficial verrucous carcinoma, the response rate at 5 years with 5-fluorouracil or imiquimod was 60% to 70% (World J Urol. 2009; 27:179-187).
In this setting, CO2 and Nd: YAG laser ablation can also be used, although retreatment rates are quite high (about 20% to 30%),